|
2007 - Review Articles
Citations 11-20 of 35 total displayed.
|
Past content
(since Jan 2007):
|
- review
Hematopoietic cell transplantation: progress and obstacles
- M Devetten and JO Armitage
Ann. Onc. 2007; 18: 1450-1456.
[Abstract]
[Full text]
[PDF]
- review
Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy
- DB Cornelio, R Roesler, and G Schwartsmann
Ann. Onc. 2007; 18: 1457-1466.
[Abstract]
[Full text]
[PDF]
- reviews
Breast cancer prognostication and prediction in the postgenomic era
- PE Lønning, S Knappskog, V Staalesen, R Chrisanthar, and JR Lillehaug
Ann. Onc. 2007; 18: 1293-1306.
[Abstract]
[Full text]
[PDF]
- reviews
New drug development in digestive neuroendocrine tumors
- I Durán, R Salazar, O Casanovas, V Arrazubi, E Vilar, LL Siu, J Yao, and J Tabernero
Ann. Onc. 2007; 18: 1307-1313.
[Abstract]
[Full text]
[PDF]
- reviews
Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations
- V Launay-Vacher, E Chatelut, SM Lichtman, H Wildiers, C Steer, and M Aapro
Ann. Onc. 2007; 18: 1314-1321.
[Abstract]
[Full text]
[PDF]
- reviews
Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines
- DD Correa, L Maron, H Harder, M Klein, CL Armstrong, P Calabrese, JEC Bromberg, LE Abrey, TT Batchelor, and D Schiff
Ann. Onc. 2007; 18: 1145-1151.
[Abstract]
[Full text]
[PDF]
- reviews
A review of the use of trastuzumab (Herceptin®) plus vinorelbine in metastatic breast cancer
- A Chan
Ann. Onc. 2007; 18: 1152-1158.
[Abstract]
[Full text]
[PDF]
- reviews
Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia (hand-foot syndrome)
- D Lorusso, A Di Stefano, V Carone, A Fagotti, S Pisconti, and G Scambia
Ann. Onc. 2007; 18: 1159-1164.
[Abstract]
[Full text]
[PDF]
- reviews
Predicting prognosis in patients with advanced cancer
- PC Stone and S Lund
Ann. Onc. 2007; 18: 971-976.
[Abstract]
[Full text]
[PDF]
- reviews
Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer
- G Valabrega, F Montemurro, and M Aglietta
Ann. Onc. 2007; 18: 977-984.
[Abstract]
[Full text]
[PDF]
|
|
Collected Resources Home
|
|
|
|